Celldex Therapeutics, Inc. Gains 82.4%

Thu 11 Jun 20 at 05:30 PM
Celldex Therapeutics, Inc. Gains 82.4%

Celldex Therapeutics, Inc. (CLDX:NASDAQ) soared at $8.76, a gain of 82.4%. On Wed 10 Jun 20, CLDX:NASDAQ touched a New 2-Week High of $4.8. The stock appeared on our News Catalysts scanner on Thu 11 Jun 20 at 02:44 PM in the 'INSIDER' category. From Wed 27 May 20, the stock recorded 50.00% Up Days and 72.73% Green Days

About Celldex Therapeutics, Inc. (CLDX:NASDAQ)

Celldex Therapeutics Inc is a biopharmaceutical company. The Company is engaged in the development and commercialization of immunotherapy technologies for the treatment of cancer and other difficult-to-treat diseases.

Share